Prostate Adenocarcinoma, TMPRSS2::ETV1 Fusion-Positive: Two Cases with Clinical and Molecular Characterization

被引：0
|
作者：
Bubar, R. [1 ]
Korentzelos, D. [1 ]
Wald, A. [1 ]
Tucker, J. [1 ]
Mohebnasab, M. [1 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2024年 / 26卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
ST130
引用
收藏
页码：S133 / S133
页数：1
相关论文
共 50 条
  • [41] Apurinic/apyrimidinic endonuclease 1 (APE1/Ref-1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2:ERG fusion
    Juhnke, Manuela
    Heumann, Asmus
    Chirico, Viktoria
    Hoeflmayer, Doris
    Menz, Anne
    Hinsch, Andrea
    Hube-Magg, Claudia
    Kluth, Martina
    Lang, Dagmar S.
    Moeller-Koop, Christina
    Sauter, Guido
    Simon, Ronald
    Beyer, Burkhard
    Pompe, Raisa
    Thederan, Imke
    Schlomm, Thorsten
    Luebke, Andreas M.
    MOLECULAR CARCINOGENESIS, 2017, 56 (09) : 2135 - 2145
  • [42] Detailed Molecular and Immune Marker Profiling of Archival Prostate Cancer Samples Reveals an Inverse Association between TMPRSS2:ERG Fusion Status and Immune Cell Infiltration
    Rao, Srinivasa R.
    Alham, Nasullah K.
    Upton, Elysia
    McIntyre, Stacey
    Bryant, Richard J.
    Cerundolo, Lucia
    Bowes, Emma
    Jones, Stephanie
    Browne, Molly
    Mills, Ian
    Lamb, Alastair
    Tomlinson, Ian
    Wedge, David
    Browning, Lisa
    Sirinukunwattana, Korsuk
    Palles, Claire
    Hamdy, Freddie C.
    Rittscher, Jens
    Verrill, Clare
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (05): : 652 - 669
  • [43] Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer
    Krook, Melanie A.
    Barker, Hannah
    Chen, Hui-Zi
    Reeser, Julie W.
    Wing, Michele R.
    Martin, Dorrelyn
    Smith, Amy M.
    Dao, Thuy
    Bonneville, Russell
    Samorodnitsky, Eric
    Miya, Jharna
    Freud, Aharon G.
    Monk, J. Paul
    Clinton, Steven K.
    Roychowdhury, Sameek
    PROSTATE CANCER AND PROSTATIC DISEASES, 2019, 22 (04) : 624 - 632
  • [44] Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer
    Melanie A. Krook
    Hannah Barker
    Hui-Zi Chen
    Julie W. Reeser
    Michele R. Wing
    Dorrelyn Martin
    Amy M. Smith
    Thuy Dao
    Russell Bonneville
    Eric Samorodnitsky
    Jharna Miya
    Aharon G. Freud
    J. Paul Monk
    Steven K. Clinton
    Sameek Roychowdhury
    Prostate Cancer and Prostatic Diseases, 2019, 22 : 624 - 632
  • [45] Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers
    Katharina Möller
    Anna Lena Wecker
    Doris Höflmayer
    Christoph Fraune
    Georgia Makrypidi-Fraune
    Claudia Hube-Magg
    Martina Kluth
    Stefan Steurer
    Till S. Clauditz
    Waldemar Wilczak
    Ronald Simon
    Guido Sauter
    Hartwig Huland
    Hans Heinzer
    Alexander Haese
    Thorsten Schlomm
    Sören Weidemann
    Andreas M. Luebke
    Sarah Minner
    Christian Bernreuther
    Sarah Bonk
    Andreas Marx
    Virchows Archiv, 2020, 477 : 625 - 636
  • [46] Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers
    Moeller, Katharina
    Wecker, Anna Lena
    Hoeflmayer, Doris
    Fraune, Christoph
    Makrypidi-Fraune, Georgia
    Hube-Magg, Claudia
    Kluth, Martina
    Steurer, Stefan
    Clauditz, Till S.
    Wilczak, Waldemar
    Simon, Ronald
    Sauter, Guido
    Huland, Hartwig
    Heinzer, Hans
    Haese, Alexander
    Schlomm, Thorsten
    Weidemann, Soeren
    Luebke, Andreas M.
    Minner, Sarah
    Bernreuther, Christian
    Bonk, Sarah
    Marx, Andreas
    VIRCHOWS ARCHIV, 2020, 477 (05) : 625 - 636
  • [47] Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
    Hong, David S.
    DuBois, Steven G.
    Kummar, Shivaani
    Farago, Anna F.
    Albert, Catherine M.
    Rohrberg, Kristoffer S.
    van Tilburg, Cornelis M.
    Nagasubramanian, Ramamoorthy
    Berlin, Jordan D.
    Federman, Noah
    Mascarenhas, Leo
    Geoerger, Birgit
    Dowlati, Afshin
    Pappo, Alberto S.
    Bielack, Stefan
    Doz, Francois
    McDermott, Ray
    Patel, Jyoti D.
    Schilder, Russell J.
    Tahara, Makoto
    Pfister, Stefan M.
    Witt, Olaf
    Ladanyi, Marc
    Rudzinski, Erin R.
    Nanda, Shivani
    Childs, Barrett H.
    Laetsch, Theodore W.
    Hyman, David M.
    Drilon, Alexander
    LANCET ONCOLOGY, 2020, 21 (04): : 531 - 540
  • [48] Molecular signature and clinical implications of TMPRSS2 and ETS transcription family genes fusions in a surgical cohort of American men treated for clinically localized prostate cancer
    Mehra, R.
    Tomlins, S.
    Shen, R.
    Wang, L.
    Wei, J.
    Pienta, K.
    Ghosh, D.
    Rubin, M. A.
    Chinniayan, A.
    Shah, R. B.
    MODERN PATHOLOGY, 2007, 20 : 163A - 163A
  • [49] Molecular signature and clinical implications of TMPRSS2 and ETS transcription family genes fusions in a surgical cohort of American men treated for clinically localized prostate cancer
    Mehra, R.
    Tomins, S.
    Shen, R.
    Wang, L.
    Pienta, K.
    Ghosh, D.
    Rubin, M. A.
    Chinniayan, A.
    Shah, R. B.
    LABORATORY INVESTIGATION, 2007, 87 : 163A - 163A
  • [50] The Prostate Cancer TMPRSS2:ERG Fusion Synergizes With the Vitamin D Receptor (VDR) to Induce CYP24A1 Expression-Limiting VDR Signaling
    Kim, Jung-Sun
    Roberts, Justin M.
    Bingman, William E., III
    Shao, Longjiang
    Wang, Jianghua
    Ittmann, Michael M.
    Weigel, Nancy L.
    ENDOCRINOLOGY, 2014, 155 (09) : 3262 - 3273
12345